⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
WVE News
Wave Life Sciences Ltd. Ordinary Shares
Form 8-K
sec.gov
WVE
Wave Life Sciences Reports Third Quarter 2026 Financial Results and Provides Business Update
globenewswire.com
WVE
Wave Life Sciences Third Quarter 2026 Financial Results Scheduled for October 27, 2026
globenewswire.com
WVE
North Carolina's Electric Cooperatives Launches EVConnectNC, Powered by WeaveGrid, to Maximize Charging During Lower Demand and Power Cost Periods
prnewswire.com
WVE
Wave Life Sciences to Host Virtual Research Day on Wednesday, November 4, 2026
globenewswire.com
WVE
Wave Life Sciences to Present at Chardan’s 10th Annual Healthcare Conference
globenewswire.com
WVE
Wave Life Sciences Announces FDA Feedback Supports Registrational Pathway for WVE-006 (RNA Editing) in AATD
globenewswire.com
WVE
Wave Life Sciences Announces GSK’s Selection of siRNA program to Transition to GSK for Further Development
globenewswire.com
WVE
Wave Life Sciences Initiates Phase 2a Combination Trial of WVE-007 (GalNAc-siRNA) with Tirzepatide for Obesity
globenewswire.com
WVE
Obesity Treatment Landscape 2026: Obesity Competitive Landscape and Clinical Trial Analysis 2026 Examines 200+ Companies and 200+ Drugs
globenewswire.com
LLY
NVO
NBIX
WVE
ALV
PFE
ABBV
AMGN
VKTX
ALNY